- Science
- Clinical Trials
- Guide to Clinical Trials Your participation makes a difference
- Clinical Trials in Children Designed to improve kids' health
- Data and Results Sharing our Results
- Integrity and Transparency Building Trust
- Diversity Equity and Representation
- Plain Language Study Results Trial Result Summaries
- Expanded Access & Compassionate Use Possible Treatment Options
- Find a Trial
- Areas of Focus
- Rare Disease Smaller populations but big impact
- Internal Medicine Extending lifespans worldwide
- Inflammation & Immunology Treatment at the molecular level
- Vaccines Preventing the spread of infections
- Oncology The science of optimism
- Anti Infectives Combatting an evolving risk
- Areas of Innovation
- Gene Therapy Breakthroughs become treatments
- Medicinal Sciences The next generation of science
- Precision Medicine Developing tailored medicines
- Maternal Immunization Protecting newborns at the start
- mRNA Technology Unleashing the next wave of scientific innovations
- Diseases & Conditions
- Coronavirus Resources
- Product Pipeline
- Research Sites
- Clinical Trials
- Products
- How Drugs are Made
- Branded vs. Generic Learn the difference
- Biologics & Biosimilars Cures found in nature
- Commitment to Quality Maintaining the highest standards
- Global Supply Strategic manufacturing locations
- Manufacturing Sites Where medicine is made in the U.S.
- Medicine Safety
- Health Literacy Learning to be well
- Treatment Choices Learning about treatment decisions
- Partnering With Patients Helping others by reporting side effects
- Tips for Patients Preventing medication errors
- Reporting Adverse Events
- Counterfeiting Preventing medication errors
- Product Safety
- Product List
- Product Contacts
- PfizerPro for Professionals
- Patient Assistance Programs
- Distributors
- How Drugs are Made
- Stories
- Newsroom
- About
- People
- Executives Our senior-most leadership
- Board Members The people steering our company
- Scientists Our experts making discoveries
- Patient Stories Our patients
- Colleague Stories Our colleagues
- Responsibility
- Ethics & Compliance Each of us is responsible
- Responsible Business Breakthroughs that change patients’ lives
- Patient Advocacy & Engagement Putting Patients First
- Global Impact Meeting urgent needs worldwide
- Diversity, Equity, and Inclusion Everyone has something to offer
- Environmental Sustainability Our responsiblity to the environment
- Human Rights Furthering dignity and worth
- Health & Safety
- Intellectual Property The benefits of fair competition
- EHS Governance
- Misinformation
- Programs & Policies
- Grants Support for independent research
- Political Partnership Supporting like-minded organizations
- Working with Healthcare Professionals Collaboration to improve lives
- Prescription Value & Pricing How to lower patient costs
- Privacy Principles Commitment to personal data privacy
- Ready for Cures Improving Access to Medicines
- Transparency in Grants Committed to Disclosure
- Policy Positions
- Investors
- Investors Overview Information for stockholders
- Why Invest Why to join us in our mission
- Events & Presentations Calendar of upcoming events
- Financial Reports Quarterly reports and more
- Investor News Announcements about our performance
- Stock Information Charts and data
- Shareholder Services Information on stock transactions
- Corporate Governance
- Corporate Governance Overview Gaining insight into our performance
- Board Committees & Charters Defining the corporate structure
- The Pfizer Board Policies Ensuring ethical leadership
- Corporate Governance FAQs Learn more about our approach
- Contact Our Directors Email any of our Directors
- Purpose
- History
- Careers
- Partners
- People
AMR Prevention
What can we all do to help prevent antimicrobial resistance (AMR)?
There are a few steps each of us can take to help prevent AMR:
While anti-infectives can help treat an infection once it occurs, vaccines can help protect against life-threatening infections and their associated consequences, including AMR.
Why are vaccines important in the fight to #StopSuperbugs?
By helping to prevent infections in the first place, vaccines can reduce the use and overuse of antibiotics which may result in resistant strains.2,3 In fact, to date, several studies have demonstrated the beneficial role that some existing vaccines play in the reduction of AMR.4,5
Vaccination can play multiple roles in antimicrobial stewardship strategies focused on AMR prevention, including:
- Reducing the use of antibiotics by preventing:
- bacterial infections including those that may carry resistance
- viral diseases which lead to secondary bacterial infections requiring antibiotic treatment
- viral diseases for which antibiotics are inappropriately prescribed
- Preventing antimicrobial resistant infections from spreading
With our innovative vaccine portfolio and pipeline, Pfizer is dedicated to helping to protect lives across all stages of life and to fight serious infectious diseases worldwide.
Value of Vaccines in AMR
Antimicrobial resistance, or AMR, is a significant public health problem affecting all areas of the world—negatively impacting millions of people and costing billions of dollars.
Read more about the value of vaccines in preventing and combating AMR. DetailsWhy are vaccines critical in helping combat the growing AMR crisis?
Antimicrobial resistance (AMR) occurs when pathogens change and find ways to resist the effects of antibiotics.
Find out more here. DetailsHandwashing Video
It may seem simple, but learn how washing your hands regularly and thoroughly can help prevent AMR.
References
- World Health Organization. Antibiotic Resistance. February 2018. Available at: http://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance. Last accessed March 2020.
- The Global Antibiotic Resistance Partnership. The Center for Disease Dynamics, Economics & Policy. State of the World's Antibiotics. 2015. Available at: https://cddep.org/wp-content/uploads/2017/06/swa_edits_9.16.pdf. Last accessed March 2020.
- Okeke, I. N., Lamikanra, A., and Edelman, R. Socioeconomic and Behavioral Factors Leading to Acquired Bacterial Resistance to Antibiotics in Developing Countries. Emerging Infectious Diseases. 1999. 5(1):18–27.
- Kwong J, et al. The Effect of Universal Influenza Immunization on Antibiotic Prescriptions: An Ecological Study. 2009. Available at: https://academic.oup.com/cid/article/49/5/750/308812. Last accessed March 2020.
- M Giufrèa, et al. Ten years of Hib vaccination in Italy: Prevalence of non-encapsulated Haemophilus influenzae among invasive isolates and the possible impact on antibiotic resistance. 2011. Available at: https://www.ncbi.nlm.nih.gov/pubmed/21459175. Last accessed March 2020.